Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0BMC Medical Genomics

Vitamin D binding protein gene polymorphisms and the risk of respiratory diseases: a meta-analysis and systematic review

  1. 1Department of Geriatric Respiratory Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
  2. 2Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

Abstract

Background: Recent studies have found that VDBP gene polymorphism is closely related to the pathogenesis of some respiratory diseases. Rs7041 and rs4588 are two major single-nucleotide polymorphisms(SNPs) in the GC gene encoding VDBP. Different combinations of these variants give rise to three major haplotypic isoforms, GC*1F, GC*1S, and GC*2, which may influence pulmonary immune-inflammatory responses and immune regulation. This systematic review and meta-analysis aimed to clarify the associations between VDBP gene polymorphisms and respiratory diseases including chronic obstructive pulmonary disease(COPD), asthma, Corona Virus Disease-2019(COVID-19) and tuberculosis, so as to provide evidence for the formulation of individualized prevention and therapeutic strategies in the future.

Methods: We searched the Pubmed, web of science, Wanfang, Embase and China National Knowledge Infrastructure(CNKI) to find the eligible case–control studies. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Forest plots were generated using Review Manager version 5.4, and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated.

Results: A total of 30 studies involving 8,844 participants were included. No significant associations were observed between the rs7041 or rs4588 polymorphism and COPD susceptibility (both P > 0.05). In the analysis of GC variants, GC*1F-related genetic models were associated with an increased risk of COPD. The ORs for GC*1F/1F versus GC*1F/1S and for GC*1F/1F versus GC*1S/1S group were 1.73 and 2.17, respectively. The OR for the GC*1F/1F homozygous comparison was 1.96, and the GC*1F allele analysis was also statistically significant (P = 0.0003). Ethnicity-based subgroup analyses suggested that GC*1F may be primarily associated with increased COPD susceptibility in East Asian populations. In non-East Asian populations, GC*2 showed a trend toward a reduced risk of COPD, although this association did not reach statistical significance (OR = 0.52, P = 0.09). In the asthma analysis, GC*2 may be associated with an increased risk of asthma (P ≤ 0.001). However, because relatively few studies were available for asthma, COVID-19, and tuberculosis, and substantial heterogeneity was present in some analyses, the current evidence remains insufficient to draw definitive conclusions regarding the associations between GC variants and these diseases.

Conclusion: The GC*1F allele and GC*1F/1F diplotype may be associated with increased susceptibility to COPD, particularly in East Asian populations, whereas no significant associations were observed between rs7041 or rs4588 and COPD risk. GC*2 may show a potentially protective trend against COPD in non-East Asian populations but may be associated with increased asthma susceptibility. Given the limited and highly heterogeneous evidence regarding asthma, COVID-19, and tuberculosis, further high-quality studies are needed to validate these findings.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12920-026-02443-1.

Related

  1. Endocrine–Immune Crosstalk in Pediatric Autoimmune Diseases: A Systematic Review of the Role of Micronutrients, with Emphasis on Vitamin D
    Atapattu Navoda, Sunil J. Wimalawansa
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  2. VITAMIN D SUPPLEMENTATION FOR THE PREVENTION OF RESPIRATORY INFECTIONS IN CHILDHOOD: A SYSTEMATIC REVIEW AND META-ANALYSIS
    H. K. P. Sousa, T. d. S. Siqueira, M. A. M. d. C. Oliveira +9
    medRxivPreprintCC BY-NCFull textObstetrics, gynaecology & paediatricsmedRxiv
  3. Respiratory syncytial virus vaccination in systemic autoimmune rheumatic diseases: a systematic review
    Victoria Allen, Maryam Adas, Liyang Pan +4
    Rheumatology (Oxford, England)Peer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  4. Common barriers and facilitators to the implementation of digital medicine in chronic respiratory diseases: a systematic review of reviews
    Julia Korel, Sebastian Kuhn, Rainer Gloeckl +16
    Frontiers in Digital HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthDOAJPMCEurope PMC
  5. Cytokine gene polymorphisms and risk for Upper Respiratory Symptoms in highly-trained athletes
    Amanda J. Cox, Maree Gleeson, David B. Pyne +3
    PubMedPeer-reviewedLicence not statedFull text25 citedPhysiologyOpenAlex
BibTeX
@article{zhang2026vitamin,
  title = {{Vitamin D binding protein gene polymorphisms and the risk of respiratory diseases: a meta-analysis and systematic review}},
  author = {Jing Zhang and Hongwen Li and Xiangyu Chi and Guoying Zhang and Hongjuan Jiang},
  journal = {BMC Medical Genomics},
  year = {2026},
  month = aug,
  doi = {10.1186/s12920-026-02443-1},
  url = {https://doi.org/10.1186/s12920-026-02443-1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Vitamin D binding protein gene polymorphisms and the risk of respiratory diseases: a meta-analysis and systematic review
AU  - Jing Zhang
AU  - Hongwen Li
AU  - Xiangyu Chi
AU  - Guoying Zhang
AU  - Hongjuan Jiang
PY  - 2026
DA  - 2026/08/13
JO  - BMC Medical Genomics
DO  - 10.1186/s12920-026-02443-1
UR  - https://doi.org/10.1186/s12920-026-02443-1
AB  - Background: Recent studies have found that VDBP gene polymorphism is closely related to the pathogenesis of some respiratory diseases. Rs7041 and rs4588 are two major single-nucleotide polymorphisms(SNPs) in the GC gene encoding VDBP. Different combinations of these variants give rise to three major haplotypic isoforms, GC*1F, GC*1S, and GC*2, which may influence pulmonary immune-inflammatory responses and immune regulation. This systematic review and meta-analysis aimed to clarify the associations between VDBP gene polymorphisms and respiratory diseases including chronic obstructive pulmonary disease(COPD), asthma, Corona Virus Disease-2019(COVID-19) and tuberculosis, so as to provide evidence for the formulation of individualized prevention and therapeutic strategies in the future.  Methods: We searched the Pubmed, web of science, Wanfang, Embase and China National Knowledge Infrastructure(CNKI) to find the eligible case–control studies. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Forest plots were generated using Review Manager version 5.4, and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated.  Results: A total of 30 studies involving 8,844 participants were included. No significant associations were observed between the rs7041 or rs4588 polymorphism and COPD susceptibility (both P > 0.05). In the analysis of GC variants, GC*1F-related genetic models were associated with an increased risk of COPD. The ORs for GC*1F/1F versus GC*1F/1S and for GC*1F/1F versus GC*1S/1S group were 1.73 and 2.17, respectively. The OR for the GC*1F/1F homozygous comparison was 1.96, and the GC*1F allele analysis was also statistically significant (P = 0.0003). Ethnicity-based subgroup analyses suggested that GC*1F may be primarily associated with increased COPD susceptibility in East Asian populations. In non-East Asian populations, GC*2 showed a trend toward a reduced risk of COPD, although this association did not reach statistical significance (OR = 0.52, P = 0.09). In the asthma analysis, GC*2 may be associated with an increased risk of asthma (P ≤ 0.001). However, because relatively few studies were available for asthma, COVID-19, and tuberculosis, and substantial heterogeneity was present in some analyses, the current evidence remains insufficient to draw definitive conclusions regarding the associations between GC variants and these diseases.  Conclusion: The GC*1F allele and GC*1F/1F diplotype may be associated with increased susceptibility to COPD, particularly in East Asian populations, whereas no significant associations were observed between rs7041 or rs4588 and COPD risk. GC*2 may show a potentially protective trend against COPD in non-East Asian populations but may be associated with increased asthma susceptibility. Given the limited and highly heterogeneous evidence regarding asthma, COVID-19, and tuberculosis, further high-quality studies are needed to validate these findings.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12920-026-02443-1.
SN  - 1755-8794
ER  -